Cleveland Clinic

Dr. Pete Anderson left high school early but went on to graduate summa cum laude from the University of Minnesota, where he began his cancer research career. He completed an MD at Mt. Sinai, a PhD at CUNY, and a combined Internal Medicine/Pediatrics residency at Duke, followed by Pediatric Hem/Onc/BMT fellowship and cancer immunology research at Minnesota. He spent a decade at the Mayo Clinic (rising to Professor) leading innovative trials, including samarium and aerosol IL-2 liposomes, and later served at MD Anderson (2005–2014) specializing in outpatient chemotherapy, immunotherapy, and sarcoma clinical trials. Now a Professor at the Cleveland Clinic Lerner College of Medicine, he remains active in patient advocacy, conducts over 300 virtual consults annually, and helps advance novel approaches using chemotherapy, SBRT, cryoablation, and immunologic strategies. He has authored 150+ publications and invented Healios, a medical nutrition product that supports GI healing and reduces mucositis.

Nationwide Children’s Hospital

Dr. Timothy Cripe is Chief of Pediatric Hematology, Oncology, Blood and Marrow Transplant and the Gordon Teter Endowed Chair in Pediatric Cancer at Nationwide Children’s Hospital. He is a principal investigator in the Center for Childhood Cancer Research at the Abigail Wexner Research Institute and a Professor of Pediatrics at The Ohio State University Wexner College of Medicine, where he is also part of the Translational Therapeutics Program and the Pelotonia Institute for Immuno-Oncology. His research centers on developing and clinically testing cellular, viral, and gene therapies for pediatric cancers, supported by multiple R-, U-, and P-level NIH grants. Dr. Cripe has published 170+ peer-reviewed papers, delivered over 220 invited lectures, and serves as PI of a T32 training grant in pediatric cancer. He is the former chair of the FDA’s Cellular, Tissue and Gene Therapy Advisory Committee and is Editor-in-Chief of Molecular Therapy – Oncology. He founded the educational podcast This Week in Pediatric Oncology (112 episodes) and is co-founder and board member of Vironexis Biotherapeutics, a clinical-stage cancer gene therapy company.

Dana-Farber / Boston Children’s

Dr. DuBois completed medical school and pediatric residency at UCSF, followed by pediatric oncology training at Dana-Farber / Boston Children’s, where he also earned an MS in Epidemiology from the Harvard School of Public Health. He is now an Associate Professor of Pediatrics at Harvard Medical School and Director of Experimental Therapeutics at Dana-Farber / Boston Children’s Cancer and Blood Disorders Center, leading efforts to bring new targeted therapies to children with cancer. His clinical and translational research focuses on advanced neuroblastoma and Ewing sarcoma, including national phase 1–3 trials and studies of biomarkers that illuminate tumor biology and drug response. Dr. DuBois has served on multiple national committees, including the COG Neuroblastoma Steering Committee, COG Bone Tumor Committee, ASCO Scientific Program Committee, and the FDA ODAC Pediatric Oncology Drugs Advisory Committee.

Hopp-Children’s Cancer Center (Germany)

Dr. Thomas Grünewald is a Principal Investigator at the German Cancer Research Center (DKFZ)/Hopp-Children’s Cancer Center (KiTZ) and Professor of Translational Pediatric Sarcoma Research at the University of Heidelberg. His work integrates functional genomics—high-throughput sequencing, transcriptomics, epigenetics, and CRISPR—with diverse in vitro and in vivo approaches to uncover mechanisms, diagnostics, and therapeutic opportunities for pediatric and AYA sarcomas. Prior to Heidelberg, he trained at TUM, completed postdoctoral research at the Institut Curie in Paris, and served as a Max-Eder Junior Research Group Leader at LMU Munich. He is also an attending pathologist at Heidelberg University Hospital and co-organizer of EuSARC conferences. Dr. Grünewald has received multiple national research and teaching awards, and his work has been cited 5,500+ times with an H-index of 41.

Memorial Sloan Kettering

Dr. Slotkin is a pediatric oncologist on the Memorial Sloan Kettering Kids team who specializes in the treatment of children with sarcomas and other solid tumors. With our strong history in the treatment of sarcomas, MSK sees one of the largest groups of children and young adults with sarcomas in the world. Dr. Slotkin’s research focuses on identifying and testing new treatments for desmoplastic small round cell tumors and other sarcomas affecting adolescents and young adults, through translational laboratory work and clinical trials.

University of Florida

Dr. Ramon Sun is an endowed chair and Associate Professor of Biochemistry at the University of Florida, where he directs the Center for Advanced Spatial Biomolecule Research. After undergraduate studies at the University of Auckland and a PhD in Cancer Biology at the Australian National University, he completed postdoctoral training at Stanford before launching his independent lab. A leading expert in spatial metabolomics, Dr. Sun develops advanced mass spectrometry and machine-learning–driven tools to map complex carbohydrate metabolism at single-cell resolution. His team integrates these data-rich approaches with cellular and mouse models to uncover how carbohydrate dysregulation drives diseases, including cancer. His recent work has illuminated the often-overlooked glycogen hyperaccumulation phenotype in Ewing sarcoma and its potential as a therapeutic target.

Georgetown University

Dr. Aykut Üren is a Professor of Oncology at Georgetown University with a secondary appointment in Biochemistry and Molecular & Cellular Biology. His research examines the molecular drivers of malignant transformation and advances drug discovery for pediatric sarcomas. His lab develops targeted therapies against key oncogenic proteins, including EWS-FLI1 and CD99 in Ewing sarcoma, ERG in prostate cancer, ezrin in osteosarcoma, and Pax3-FOXO1 in rhabdomyosarcoma. Dr. Üren also directs Georgetown’s core facility for surface plasmon resonance (Biacore) technology, supporting academic and industry partners. A dedicated educator, he teaches tumor biology and medical gross anatomy and has received multiple teaching honors, including the Golden Apple and Golden Orchard awards.

Various Institutions, Globally

In addition to our formal Medical Advisory Board, we engage a network of leading medical and scientific experts who contribute their specialized knowledge on an as-needed basis. They are not formal board members, but they ensure each opportunity is assessed with the highest level of scientific and clinical rigor. We are grateful for the generosity of so many physicians and researchers who lend their brainpower and their hearts to this cause.